Advertisement

Topics

Favrille Company Profile

11:45 EST 24th November 2017 | BioPortfolio

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a proprietary technology that enables us to efficiently develop and manufacture active immunotherapy products designed to stimulate a patient's own immune system to mount a specific and sustained response to disease. Our lead product candidate, FavId®, is an active immunotherapy for the treatment of B-cell non-Hodgkin's lymphoma. We completed enrollment in a pivotal Phase 3 clinical trial of FavId in January 2006. The randomized, double-blind, placebo-controlled registration trial is designed to evaluate FavId following Rituxan®, the current standard of care, for the treatment of follicular B-cell non-Hodgkin's lymphoma. We have a Special Protocol Assessment from the U.S. Food & Drug Administration (FDA) for our Phase 3 trial. FavId has also received Fast Track designation from the FDA. Analysis of the primary endpoint, time to disease progression, is expected during the fourth quarter of 2007. In addition to our pivotal Phase 3 trial, we have additional Phase 2 and Phase 2/3 clinical trials of FavId ongoing in other B-cell non-Hodgkin's lymphoma indications. We are also developing additional applications based upon our immunotherapy expertise and proprietary technology, including a second product candidate, FAV-201, for the treatment of cutaneous T-cell lymphoma.

Location

10445 Pacific Center Court
San Diego,
California
92121
United States of America

Contact

Phone: 858-526-8000
Fax: 858-597-7040
Email: hr@favrille.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Favrille, Inc.

Favrille, Inc. is a biopharmaceutical company focused on the development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system.

Favrille

We are a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system. We own a pr...

More Information about "Favrille" on BioPortfolio

We have published hundreds of Favrille news stories on BioPortfolio along with dozens of Favrille Clinical Trials and PubMed Articles about Favrille for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Favrille Companies in our database. You can also find out about relevant Favrille Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record